Creativity doesn’t belong to the young, patents show

"Although the peak of patents awarded are for those in midlife, there are inventors who are patenting well into later life."

Jarret Bencks-Brandeis • futurity
Nov. 14, 2022 ~6 min

Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier

Drug repurposing can redeem failed treatments and squeeze out new uses from others. But many pharmaceutical companies are hesitant to retool existing drugs without a high return on investment.

Jonathan Sexton, Assistant Professor of Internal Medicine and Medicinal Chemistry, University of Michigan • conversation
April 6, 2022 ~11 min


CORBEVAX, a new patent-free COVID-19 vaccine, could be a pandemic game changer globally

CORBEVAX is anticipated to significantly expand vaccine access to people in low- and middle-income countries.

Maureen Ferran, Associate Professor of Biology, Rochester Institute of Technology • conversation
Jan. 19, 2022 ~9 min

Why Moderna won't share rights to the COVID-19 vaccine with the government that paid for its development

Moderna claims its scientists alone invented the mRNA sequence used to produce its COVID-19 vaccine. The US government, which helped fund the drug, disagrees.

Ana Santos Rutschman, Assistant Professor of Law, Saint Louis University • conversation
Nov. 18, 2021 ~11 min

A comprehensive study of technological change

New research using patent data could help inform decision-makers by predicting which technologies are improving the fastest.

Scott Murray | Institute for Data, Systems, and Society • mit
Aug. 2, 2021 ~6 min

Too few women get to invent – that's a problem for women's health

Boosting the number of female inventors isn't just a matter of fairness. Inventions by men are more likely to ignore women's needs.

Rem Koning, Assistant Professor of Business Administration, Harvard Business School • conversation
June 17, 2021 ~8 min

US support for waiving COVID-19 vaccine patent rights puts pressure on drugmakers – but what would a waiver actually look like?

The process will take months, if it's even approved. But just the threat of waiving intellectual property rights could spur faster action.

Dalindyebo Shabalala, Associate Professor, University of Dayton • conversation
May 10, 2021 ~9 min

How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakers

India and South Africa are pressing the World Trade Organization to waive patent rights to help ramp up vaccine production. There's a better solution.

Dalindyebo Shabalala, Associate Professor, University of Dayton • conversation
April 14, 2021 ~9 min


Patent system often stifles the innovation it was designed to encourage

Too many patents and too little information about them makes it hard for the system to weed out patents that unfairly block inventors.

Janet Freilich, Associate Professor of Law, Fordham University • conversation
March 16, 2021 ~11 min

The iconic American inventor is still a white male – and that's an obstacle to race and gender inclusion

The story of the invention in America typically features larger-than-life caricatures of white men like Thomas Edison while largely ignoring the contributions of women and people of color.

Anjali Vats, Associate Professor of Communication and African and African Diaspora Studies and Associate Professor of Law (By Courtesy), Boston College • conversation
Dec. 8, 2020 ~9 min

/

3